Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons
M Thouaye, I Yalcin - Pharmacology & Therapeutics, 2023 - Elsevier
Neuropathic pain, caused by a lesion or disease affecting the somatosensory system, affects
between 3 and 17% of the general population. The treatment of neuropathic pain is …
between 3 and 17% of the general population. The treatment of neuropathic pain is …
Use of botulinum toxin in treating rosacea: a systematic review
H Zhang, K Tang, Y Wang, R Fang… - Clinical, Cosmetic and …, 2021 - Taylor & Francis
Background Rosacea is a chronic skin disorder characterized by erythema, flushing,
telangiectasia, papules and pustules, phymatous changes, and ocular involvement. The aim …
telangiectasia, papules and pustules, phymatous changes, and ocular involvement. The aim …
Clinical efficacy of botulinum toxin type A in the treatment of fasciitis pain: A systematic review and meta-analysis
TT Li, ZY Liu, L **ong, ZW Zhang - Medicine, 2023 - journals.lww.com
Background: The purpose of this meta-analysis was to assess the effectiveness of botulinum
toxin type A (BoNT-A) in reducing pain associated with fasciitis. By synthesizing the findings …
toxin type A (BoNT-A) in reducing pain associated with fasciitis. By synthesizing the findings …
[HTML][HTML] The access and invasiveness-based classification of medical procedures to clarify non-invasive from different forms of minimally invasive and open surgery
MS Whiteley, SE Davey… - Journal of Minimal Access …, 2024 - journals.lww.com
Background: The rapid development of less invasive and traumatic medical procedures has
resulted in a mixture of terms used to describe them, without any agreed definition for each …
resulted in a mixture of terms used to describe them, without any agreed definition for each …
[PDF][PDF] The AI classification (access and invasiveness) of medical procedures to clarify non-invasive from different forms of minimally invasive and open surgery
MS Whiteley, SE Davey, GM Placzek - 2023 - osf.io
Background: The rapid development of less invasive and traumatic medical procedures has
resulted in a mixture of terms used to describe them, without any agreed definition for each …
resulted in a mixture of terms used to describe them, without any agreed definition for each …
[BOOK][B] Lasers in Cosmetic Dermatology & Skincare Practice
E Hernandez-Jimenez - 2024 - books.google.com
Much has been written about lasers, but only a few books cover laser cosmetic dermatology
from beginning to end. We decided to address this gap and collected all the information that …
from beginning to end. We decided to address this gap and collected all the information that …
Novel cell penetrating peptides and uses thereof
WS Choi, HS Park, K Da Som, TK Park - US Patent App. 17/292,005, 2022 - Google Patents
Background [0003] In general, botulinum toxin (BTX) is a toxin pro duced by Clostridium
botulinum, a gram-positive anaerobic bacterium, and it has a mechanism that induces the …
botulinum, a gram-positive anaerobic bacterium, and it has a mechanism that induces the …
Recombinant proteins comprising botulinum toxin and cell penetrating peptide and cosmetic composition comprising thereof
WS Choi, HS Park, K Da Som, TK Park - US Patent 12,023,400, 2024 - Google Patents
Disclosed herein is a recombinant protein including botulinum toxin and cell penetrating
peptides and cosmetic composition. The cell penetrating peptide according to the present …
peptides and cosmetic composition. The cell penetrating peptide according to the present …
[CITATION][C] Clinical efficacy of botulinum toxin type A in the treatment of fasciitis pain
MM Tong-Tong Li, MM Zhong-Yuan Liu… - 2023 - europepmc.org
Background: The purpose of this meta-analysis was to assess the effectiveness of botulinum
toxin type A (BoNT-A) in reducing pain associated with fasciitis. By synthesizing the findings …
toxin type A (BoNT-A) in reducing pain associated with fasciitis. By synthesizing the findings …